Why Glimpse Group Shares Are Trading Lower By Around 41%; Here Are 20 Stocks Moving Premarket
Portfolio Pulse from Lisa Levin
Several stocks have shown significant movement in pre-market trading. Notable gainers include RVL Pharmaceuticals, Novo Integrated Sciences, Polished.com, OpGen, Brooge Energy, iSun, T2 Biosystems, OPKO Health, Better Therapeutics, and NIKE. On the other hand, The Glimpse Group, Tonix Pharmaceuticals, Vaccinex, Bionomics, FLJ Group, ReShape Lifesciences, Femasys, Baudax Bio, Quince Therapeutics, and Ostin Technology Group have seen a decrease in their share prices.
September 29, 2023 | 12:15 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Brooge Energy shares rose 23% in pre-market trading after gaining 7% on Thursday.
The significant increase in Brooge Energy's share price is likely due to positive market sentiment.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Better Therapeutics shares rose 10.1% in pre-market trading after completing Enrollment in real-world evidence program evaluating long-term effectiveness of AspyreRx in Type 2 Diabetes.
The significant increase in Better Therapeutics' share price is likely due to the completion of Enrollment in a real-world evidence program evaluating the long-term effectiveness of AspyreRx in Type 2 Diabetes.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
iSun gained 18.3% in pre-market trading after recently filing for offering of up to 10.96 million shares of common stock by the selling stockholders.
The significant increase in iSun's share price is likely due to the company's recent filing for offering of up to 10.96 million shares of common stock by the selling stockholders.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
NIKE shares climbed 8.1% in pre-market trading after posting upbeat quarterly earnings.
The significant increase in NIKE's share price is likely due to the company posting upbeat quarterly earnings.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Novo Integrated Sciences shares rose 86% in pre-market trading after signing a One Billion Dollar Master Collateral Transfer Agreement with Blacksheep Trust.
The significant increase in Novo Integrated Sciences' share price is likely due to the signing of a major agreement with Blacksheep Trust.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
OpGen shares gained 34.3% in pre-market trading.
The significant increase in OpGen's share price is likely due to positive market sentiment.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
OPKO Health shares jumped 12% in pre-market trading after OPKO's ModeX Therapeutics has been awarded a BARDA Contract to develop novel multispecific antibodies against viral infectious disease threats.
The significant increase in OPKO Health's share price is likely due to ModeX Therapeutics being awarded a BARDA Contract to develop novel multispecific antibodies against viral infectious disease threats.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Polished.com shares surged 35% in pre-market trading as the company plans to hold a special meeting of stockholders to approve reverse stock split.
The significant increase in Polished.com's share price is likely due to the company's plan to hold a special meeting of stockholders to approve reverse stock split.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
RVL Pharmaceuticals shares rose 181.8% in pre-market trading.
The significant increase in RVL Pharmaceuticals' share price is likely due to positive market sentiment.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
T2 Biosystems shares rose 17.2% in pre-market trading.
The significant increase in T2 Biosystems' share price is likely due to positive market sentiment.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Bionomics shares fell 15.7% in pre-market trading after the company announced the ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant reduction in total PTSD symptom severity at 12 weeks.
The significant decrease in Bionomics' share price is likely due to the company announcing positive results from the ATTUNE trial.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Baudax Bio shares fell 11.5% in pre-market trading after the company announced it was granted orphan drug designation by the FDA for TI-168 for the treatment of Hemophilia A with inhibitors.
The significant decrease in Baudax Bio's share price is likely due to market correction after the company was granted orphan drug designation by the FDA for TI-168.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Femasys fell 11.8% in pre-market trading after recently receiving FDA 510(k) clearance for FemaSeed, an infertility treatment designed to deliver sperm directly to where conception occurs in a woman's fallopian tube.
The significant decrease in Femasys' share price is likely due to market correction after the company recently received FDA 510(k) clearance for FemaSeed.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
FLJ Group shares fell 14.7% in pre-market trading after gaining 30% on Thursday.
The significant decrease in FLJ Group's share price is likely due to market correction after a significant gain on Thursday.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Ostin Technology Group shares fell 11% in pre-market trading after declining around 8% on Thursday.
The significant decrease in Ostin Technology Group's share price is likely due to market correction after a significant decline on Thursday.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Quince Therapeutics shares fell 11.2% in pre-market trading after the FDA lifted partial clinical hold lifted on IND for EryDel's lead Phase 3 asset EryDex.
The significant decrease in Quince Therapeutics' share price is likely due to the FDA lifting partial clinical hold on IND for EryDel's lead Phase 3 asset EryDex.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
ReShape Lifesciences shares fell 13.6% in pre-market trading after dipping 15% on Thursday.
The significant decrease in ReShape Lifesciences' share price is likely due to market correction after a significant dip on Thursday.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Tonix Pharmaceuticals shares fell 36.8% in pre-market trading after the company reported pricing of $4.5 million public offering.
The significant decrease in Tonix Pharmaceuticals' share price is likely due to the company reporting pricing of a $4.5 million public offering.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Vaccinex shares fell 29.8% in pre-market trading after the company reported pricing of $9.6 million public offering.
The significant decrease in Vaccinex's share price is likely due to the company reporting pricing of a $9.6 million public offering.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
The Glimpse Group shares fell 41.2% in pre-market trading after the company reported a wider FY23 loss.
The significant decrease in The Glimpse Group's share price is likely due to the company reporting a wider FY23 loss.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100